California lawmakers could soon clear a governmental logjam that has held up dozens of studies related to addiction treatment, psychedelics or other federally restricted drugs. The holdup revolves around the Research Advisory Panel of California, established decades ago to vet studies involving cannabis, hallucinogens and treatments for "abuse of controlled substances." It has been a critical hurdle for California researchers exploring possible uses of psychedelics or seeking new ways to combat... Read this story
